Trial Profile
Quetiapine Induced Neuroplasticity in Schizophrenic Patients: A Combined TMS [transcranial magnetic stimulation] and VBM [voxel-based morphometry] Study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Schizophrenia
- Focus Pharmacodynamics
- 23 May 2013 New source identified and integrated (European Clinical Trials Database, EudraCT2007-000545-35).
- 21 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 Nov 2010 Planned end date changed from 1 Mar 2010 to 1 Mar 2011 as reported by ClinicalTrials.gov.